CARDIOFLOW-B News

CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024

Jan 6 18:49

CARDIOFLOW-B: VOLUNTARY ANNOUNCEMENT - NMPA APPROVAL FOR REGISTRATION OFVITAFLOW LIBERTY FLEX

Dec 17, 2024 22:51

CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024

Dec 4, 2024 20:48

CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024

Nov 6, 2024 16:30

CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

Oct 7, 2024 16:29

CARDIOFLOW-B: PROVISION OF GUARANTEES FOR MP CARDIOADVENT AND REVISION OF ANNUAL CAP FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE 2023 MASTER SERVICE PROCUREMENT AGREEMENT

Sep 30, 2024 16:57

CARDIOFLOW-B: 2024 Interim Report

Sep 26, 2024 16:52

CARDIOFLOW-B: POLL RESULTS OF EXTRAORDINARY GENERAL MEETINGHELD ON SEPTEMBER 20, 2024

Sep 20, 2024 18:52

CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

Sep 5, 2024 16:32

CARDIOFLOW-B: FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, SEPTEMBER 20, 2024

Aug 29, 2024 18:55

CARDIOFLOW-B: NOTICE OF EXTRAORDINARY GENERAL MEETING

Aug 29, 2024 18:52

CARDIOFLOW-B: DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF THE ENTIRE EQUITY INTEREST OF THE TARGET COMPANY AND NOTICE OF EXTRAORDINARY GENERAL MEETING

Aug 29, 2024 18:50

CARDIOFLOW-B: ANNOUNCEMENT OF UNAUDITED INTERIM RESULTSFOR THE SIX MONTHS ENDED JUNE 30, 2024

Aug 28, 2024 22:44

CARDIOFLOW-B: DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATIONTO THE ACQUISITION OF THE ENTIRE EQUITY INTEREST OFTHE TARGET COMPANY

Aug 22, 2024 22:58

CARDIOFLOW-B: DATE OF BOARD MEETING

Aug 14, 2024 16:33

CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 5, 2024 17:01

CARDIOFLOW-B: PROFIT FORECAST FOR THE FIRST HALF OF 2024 -SIGNIFICANT REDUCTION IN NET LOSS OFAPPROXIMATELY 63% TO 72%

Jul 24, 2024 21:18

CARDIOFLOW-B: Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Jul 22, 2024 17:07

CARDIOFLOW-B: Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Jul 22, 2024 17:02

CARDIOFLOW-B: CONTINUING CONNECTED TRANSACTIONIN RELATION TOTHE 2024 KEWEI DISTRIBUTION FRAMEWORK AGREEMENTANDCONNECTED TRANSACTIONIN RELATION TO THE KEWEI LOAN AGREEMENT

Jul 19, 2024 22:50